Ways light scattering technologies help you if you’re in gene therapy

You require stable and pure AAV vectors to ensure your gene therapy product is safe and effective.

To develop effective vectors, you need to assess a number of their Critical Quality Attributes (CQAs). Technologies like static light scattering (SLS) and dynamic light scattering (DLS) give you lots of insight into your viral vector CQAs, including their size, purity, tendency to aggregate, and even how much genetic material they contain.

Check out this infographic to learn what SLS and DLS tell you about your vector samples, and how this info helps you develop better gene therapy products.

Previous Article
8 Gene Therapy conferences you should attend in 2022
8 Gene Therapy conferences you should attend in 2022

With the first AAV-based gene therapies approved, and new gene editing strategies emerging, it’s important ...

Up next
Four technologies to profile your AAVs
Four technologies to profile your AAVs

[New] Prometheus Panta with SLS

Build effective AAV vectors for gene therapy with
high-quality stability profiling data

Learn more